Cargando…
Electrophysiological basis of cardiac arrhythmia in a mouse model of myotonic dystrophy type 1
Introduction: Myotonic dystrophy type 1 (DM1) is a multisystemic genetic disorder caused by the increased number of CTG repeats in 3′ UTR of Dystrophia Myotonia Protein Kinase (DMPK) gene. DM1 patients experience conduction abnormalities as well as atrial and ventricular arrhythmias with increased s...
Autores principales: | Ginjupalli, Vamsi Krishna Murthy, Cupelli, Michael, Reisqs, Jean-Baptiste, Sleiman, Yvonne, El-Sherif, Nabil, Gourdon, Genevieve, Puymirat, Jack, Chahine, Mohamed, Boutjdir, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551179/ https://www.ncbi.nlm.nih.gov/pubmed/37811496 http://dx.doi.org/10.3389/fphys.2023.1257682 |
Ejemplares similares
-
Recent Progress and Challenges in the Development of Antisense Therapies for Myotonic Dystrophy Type 1
por: De Serres-Bérard, Thiéry, et al.
Publicado: (2022) -
iPSC-derived cardiomyocytes from patients with myotonic dystrophy type 1 have abnormal ion channel functions and slower conduction velocities
por: Poulin, Hugo, et al.
Publicado: (2021) -
Cardiac involvement in patient-specific induced pluripotent stem cells of myotonic dystrophy type 1: unveiling the impact of voltage-gated sodium channels
por: Pierre, Marion, et al.
Publicado: (2023) -
Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1
por: Ait Benichou, Siham, et al.
Publicado: (2022) -
Myotonic Dystrophies: State of the Art of New Therapeutic Developments for the CNS
por: Gourdon, Genevieve, et al.
Publicado: (2017)